Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021
Importance Vaccination against COVID-19 provides clear public health benefits, but
vaccination also carries potential risks. The risks and outcomes of myocarditis after COVID-
19 vaccination are unclear. Objective To describe reports of myocarditis and the reporting
rates after mRNA-based COVID-19 vaccination in the US. Design, Setting, and Participants
Descriptive study of reports of myocarditis to the Vaccine Adverse Event Reporting System
(VAERS) that occurred after mRNA-based COVID-19 vaccine administration between …
vaccination also carries potential risks. The risks and outcomes of myocarditis after COVID-
19 vaccination are unclear. Objective To describe reports of myocarditis and the reporting
rates after mRNA-based COVID-19 vaccination in the US. Design, Setting, and Participants
Descriptive study of reports of myocarditis to the Vaccine Adverse Event Reporting System
(VAERS) that occurred after mRNA-based COVID-19 vaccine administration between …